LTBR

Business Context and Reporting Period

Company: LIGHTBRIDGE Corp (LTBR)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: Lightbridge is a nuclear fuel technology company developing metallic uranium-zirconium fuel for water-cooled reactors. The company operates as a single segment focused on research and development (R&D) and commercialization. It has no operating revenue and relies on equity financing and interest income to fund operations.

Key Financial Metrics

Note: The company reported no debt. Liquidity is driven by cash reserves and At-The-Market (ATM) equity offerings.

Material Changes vs. Prior Period

• Net Loss Increase: Net loss for the nine months ended September 30, 2025, increased to $12.39 million from $7.85 million in the same period in 2024. This 57% increase was driven by higher operating expenses.
• Operating Expenses: Total operating expenses rose 63% year-over-year to $14.49 million.
  • G&A Expenses: Increased 61% to $9.15 million, primarily due to a $1.7 million increase in stock-based compensation (accelerated vesting and new performance awards) and higher professional fees.
  • R&D Expenses: Increased 66% to $5.35 million, driven by increased labor costs for the Idaho National Laboratory (INL) project and higher allocated employee compensation.
• Interest Income: Increased 110% to $2.10 million for the nine-month period, resulting from higher cash balances invested in U.S. Treasury instruments following ATM sales.
• Cash Position: Cash and cash equivalents surged from $40.0 million at December 31, 2024, to $153.3 million at September 30, 2025, an increase of $113.3 million.
• Financing Activity: The company raised net proceeds of $120.4 million from the sale of approximately 9.9 million shares under its ATM program during the nine months ended September 30, 2025, compared to $3.7 million in the prior year period.

Guidance, Outlook, and Risks

• Outlook: Management anticipates investing approximately $12.0 million in R&D for the full year 2025. The company expects to continue incurring significant operating losses as it advances fuel development.
• Liquidity: With $153.3 million in cash, management believes it has sufficient liquidity to fund operations for at least the next 12 months. Long-term capital requirements will likely be met through additional equity issuances, strategic partnerships, or government grants.
• Key Developments:
  • Successfully loaded capsules containing Lightbridge Fuel material samples into the Advanced Test Reactor (ATR) at INL for irradiation testing in October 2025.
  • Entered into a new $0.8 million agreement with Numerical Advisory Solutions for safety analysis code development.
  • Extended INL agreements (CRADA and SPPA) with total estimated costs of approximately $6.8 million.
• Risks:
  • Funding: Continued dependence on equity markets (ATM) for liquidity; potential dilution to shareholders.
  • Development: Uncertainty regarding R&D timelines, regulatory approvals, and the ability to commercialize fuel by the 2030s.
  • Partnerships: Reliance on INL and other strategic partners for testing and development.

Investor Verification Checklist

• ATM Capacity: Verify the remaining capacity under the current $75.0 million ATM agreement with Jefferies LLC and the status of the $150.0 million shelf registration.
• INL Milestones: Confirm the schedule and cost implications of the ongoing irradiation testing at the Idaho National Laboratory (INL) and the $6.8 million total estimated cost for current agreements.
• Stock-Based Compensation: Review the impact of the $17.1 million restricted stock award program granted in August 2025 on future quarterly expenses and dilution.
• Cash Burn Rate: Monitor the monthly cash burn rate against the $153.3 million cash balance to validate the 12-month liquidity runway.
• Regulatory Pathway: Track progress on the Fuel Qualification Plan and engagement with the Nuclear Regulatory Commission (NRC).